Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC.ADIL · Entity 7742 | Director | April 07, 2026 | April 09, 2026 |
| Twin Vee PowerCats, Co.VEEE · Entity 8235 | Director | March 19, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADIAL PHARMACEUTICALS, INC.
Report date April 07, 2026 · Filed April 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,213 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Grant · Acquired 9,185 · Balance 9,213 F1: Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectOwned by Mr. Schuyler's wife, Carolyn M. Schuyler | 4 |
Reported balance
Holding disclosure · report date 2026-04-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4 |
| Common StockSEC Table I · non-derivative | IndirectOwned by MVA 151 Investors, LLC | 230 |
Reported balance
Holding disclosure · report date 2026-04-07 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 230 F2: Mr. Schuyler has control over MVA 151 Investors, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date.
F2: Mr. Schuyler has control over MVA 151 Investors, LLC.
Twin Vee PowerCats, Co.
Report date March 19, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 31,252 |
Reported balance
After 2026-03-19 transaction · row 1
1 source rowRow 1 · 2026-03-19 · Purchase · Acquired 25,000 · Balance 31,252 F1: Open market purchase of shares in accordance with Issuer's trading policies. |
Filing footnotes · ownership attribution and instrument terms
F1: Open market purchase of shares in accordance with Issuer's trading policies.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Forza X1, Inc.
Report date November 26, 2024 · Filed November 26, 2024
Section 16 reporting ended · disclosed 2024-11-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-11-26 transaction · row 1
1 source rowRow 1 · 2024-11-26 · Disposition to issuer · Disposed 100,000 · Balance 0 F1: Disposed of pursuant to the merger (the "Merger") of Twin Vee Merger Sub, Inc. a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza X1, Inc. ("Forza"), in exchange for 61,166 shares of Twin Vee common stock. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2032-09-01 | Direct | 0 |
Reported balance
After 2024-11-26 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-11-26 · Disposition to issuer · Disposed 5,500 · Balance 0 F2: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. F3: This option was assumed by Twin Vee in the Merger and replaced with an option to purchase 3,364 shares of Twin Vee common stock for $8.17 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the merger (the "Merger") of Twin Vee Merger Sub, Inc. a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza X1, Inc. ("Forza"), in exchange for 61,166 shares of Twin Vee common stock. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger.
F2: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022.
F3: This option was assumed by Twin Vee in the Merger and replaced with an option to purchase 3,364 shares of Twin Vee common stock for $8.17 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 07, 2026 Filed Apr 9, 2026 21:00 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantCommon Stock | 9,185 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-042052 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,213 F1 · shares: Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| March 19, 2026 Filed Mar 19, 2026 21:01 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | PurchaseCommon stock | 25,000 | $0.41 | $10,165.00 |
DisclosureSEC source: 0001731122-26-000462 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,252 F1 · kind: Open market purchase of shares in accordance with Issuer's trading policies. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:01 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0001213900-25-050018 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2035-05-28 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025. Read SEC document |
| May 19, 2025 Filed May 21, 2025 12:55 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | GrantStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001731122-25-000796 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2035-05-19 F1 · shares: Consists of options to purchase shares of common stock that vest pro rata on a monthly basis over nine months commencing on May 19, 2025 and are exercisable for a period of ten years from the date of grant (subject to earlier expiration in connection with the termination of service with the Corporation). F1 · derivative.exercise_date: Consists of options to purchase shares of common stock that vest pro rata on a monthly basis over nine months commencing on May 19, 2025 and are exercisable for a period of ten years from the date of grant (subject to earlier expiration in connection with the termination of service with the Corporation). Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 16:59 UTC | Forza X1, Inc. FRZA · Entity 85653 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,500 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001731122-24-001893 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,500 shares Expires 2032-09-01 F2 · shares: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. F3 · price: This option was assumed by Twin Vee in the Merger and replaced with an option to purchase 3,364 shares of Twin Vee common stock for $8.17 per share. F2 · derivative.exercise_date: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 16:59 UTC | Forza X1, Inc. FRZA · Entity 85653 | Disposition to issuerCommon Stock | 100,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-24-001893 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Disposed of pursuant to the merger (the "Merger") of Twin Vee Merger Sub, Inc. a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza X1, Inc. ("Forza"), in exchange for 61,166 shares of Twin Vee common stock. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger. F1 · price: Disposed of pursuant to the merger (the "Merger") of Twin Vee Merger Sub, Inc. a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza X1, Inc. ("Forza"), in exchange for 61,166 shares of Twin Vee common stock. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 21:57 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | GrantStock Option (Right to Buy) · Derivative | 3,364 | Not disclosed Strike: $8.17 | Not disclosed |
DisclosureSEC source: 0001731122-24-001888 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,364 Underlying: Common Stock · 3,364 shares Expires 2032-09-01 F2 · shares: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. F3 · price: Received in the Merger in exchange for a stock option to acquire 5,500 shares of Forza common stock. F2 · derivative.exercise_date: Consists of options to purchase shares of common stock that are fully vested and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. Read SEC document |
| November 26, 2024 Filed Nov 26, 2024 21:57 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | GrantCommon Stock | 61,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001731122-24-001888 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,530 F1 · shares: Received in exchange for 100,000 shares of Forza X1, Inc. ("Forza") common stock issued in connection with the merger (the "Merger") of Twin Vee Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger. F1 · price: Received in exchange for 100,000 shares of Forza X1, Inc. ("Forza") common stock issued in connection with the merger (the "Merger") of Twin Vee Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Twin Vee PowerCats Co., a Delaware corporation ("Twin Vee"), into Forza. Each share of Forza common stock was exchanged for 0.611666275 shares of Twin Vee common stock on the effective date of the Merger. Read SEC document |
| September 17, 2024 Filed Sep 18, 2024 08:00 UTC | Forza X1, Inc. FRZA · Entity 85653 | PurchaseCommon Stock | 90,668 | $0.30 | $27,200.40 |
DisclosureSEC source: 0001731122-24-001435 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Read SEC document |
| August 16, 2024 Filed Aug 20, 2024 20:05 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | GrantStock Options (Right to Buy) · Derivative | 5,500 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001731122-24-001298 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2034-08-15 F1 · shares: Consists of options to purchase 5,500 shares of our common stock that vest immediately and are exercisable for a period of ten years from date of grant, commencing on August 16, 2024. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 22:06 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001213900-24-026708 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2034-03-24 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 12:54 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | PurchaseCommon Stock | 700 | $2.74 | $1,918.00 |
DisclosureSEC source: 0001013762-23-000757 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700 F1 · price: The price reported is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $2.72 through $2.78, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 23, 2023 Filed May 25, 2023 20:45 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001213900-23-043125 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-05-23 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023. Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 17:36 UTC | Forza X1, Inc. FRZA · Entity 85653 | PurchaseCommon Stock | 5,000 | $1.14 | $5,710.00 |
DisclosureSEC source: 0001731122-22-002174 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,332 Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 22:34 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | PurchaseCommon Stock | 600 | $1.77 | $1,062.00 |
DisclosureSEC source: 0001731122-22-002172 · ownership.xml · nonDerivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,363 Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 22:34 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | PurchaseCommon Stock | 763 | $1.79 | $1,365.77 |
DisclosureSEC source: 0001731122-22-002172 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763 Read SEC document |
| December 20, 2022 Filed Dec 21, 2022 18:39 UTC | Forza X1, Inc. FRZA · Entity 85653 | PurchaseCommon Stock | 4,332 | $1.20 | $5,198.40 |
DisclosureSEC source: 0001731122-22-002167 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,332 Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 06:04 UTC | Forza X1, Inc. FRZA · Entity 85653 | GrantStock Options (right to purchase) · Derivative | 5,500 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001731122-22-001357 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2032-08-11 F1 · shares: Consists of options to purchase 5,500 shares of common stock that will vest pro rata on a monthly basis over a twelve-month period and exercisable for a period of ten years from the date of grant, commencing on September 1, 2022. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 20:20 UTC | Twin Vee PowerCats, Co. VEEE · Entity 8235 | GrantStock Options (right to purchase) · Derivative | 5,500 | $0.00 Strike: $2.62 | $0.00 |
DisclosureSEC source: 0001731122-22-001197 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2032-07-05 F1 · shares: Consists of options to purchase 5,500 shares of common stock that will vest pro rata on a monthly basis over a twelve-month period and exercisable for a period of ten years from the date of grant, commencing on August 1, 2022. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 19:59 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001213900-22-009430 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-02-22 F1 · shares: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022. Read SEC document |
| December 23, 2021 Filed Dec 23, 2021 22:04 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 90,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001213900-21-067352 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2023-07-31 F1 · kind: Mr. Schuyler gifted the securities to a newly formed charitable trust (the "Trust"), the trustee of which is his adult son who controls the Trust. Read SEC document |
| December 23, 2021 Filed Dec 23, 2021 22:04 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftCommon Stock | 312,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-067352 · ownership.xml · nonDerivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Mr. Schuyler gifted the securities to a newly formed charitable trust (the "Trust"), the trustee of which is his adult son who controls the Trust. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:56 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option · Derivative | 40,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001213900-21-008168 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-07 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 12 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 82,461 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 11 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,461 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 10 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,900 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 9 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrants to purchase common stock · Derivative | 8,649 | Not disclosed Strike: $7.63 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 8 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,649 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 1,010 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 7 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,010 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 6 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrants to purchase common stock · Derivative | 82,461 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 5 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 82,461 Underlying: Common Stock · 82,461 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrants to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrants to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 3 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrants to purchase common stock · Derivative | 8,649 | Not disclosed Strike: $7.63 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8,649 Underlying: Common Stock · 8,649 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 21:48 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GiftWarrant to purchase common stock · Derivative | 1,010 | Not disclosed Strike: $0.01 | Not disclosed |
DisclosureSEC source: 0001213900-20-039336 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,010 Underlying: Common Stock · 1,010 shares Expires 2023-07-31 F1 · price: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · derivative.underlying: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. F1 · ownership.nature: Represents a transfer of warrants from Mr. Kevin Schuyler to The Kevin William Schuyler 2020 Irrevocable Perpetuities Trust, the trustee of which is Mr. Schuyler's wife and the beneficiaries of which are Mr. Schuyler's wife and children. Read SEC document |
| March 03, 2020 Filed Mar 6, 2020 00:21 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | GrantStock Option · Derivative | 60,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001213900-20-005547 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-03-02 F1 · shares: The option vests pro rata on a monthly basis over 36 months. F1 · derivative.exercise_date: The option vests pro rata on a monthly basis over 36 months. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 162,200 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 6 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 162,200 Underlying: Common Stock · 162,200 shares Expires 2023-07-31 F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 162,200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 5 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 162,200 Underlying: Common Stock · 162,200 shares Expires 2023-07-31 F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 162,200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 0 Underlying: Units · 324,400 shares Expires 2023-07-31 F2 · shares: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: On November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 162,200 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 162,200 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 120,000 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 3 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2023-07-31 F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 120,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2023-07-31 F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 23:49 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 120,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-015557 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Units · 240,000 shares Expires 2023-07-31 F1 · shares: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. F1 · price: On November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 120,000 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 120,000 shares of common stock. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 192,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 6 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 192,600 Underlying: Common Stock · 192,600 shares Expires 2023-07-31 F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 192,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 5 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 192,600 Underlying: Common Stock · 192,600 shares Expires 2023-07-31 F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 192,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 4 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors LLC Disclosed balance after: 0 Underlying: Units · 385,200 shares Expires 2023-07-31 F2 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. F2 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, MVA 151 Investors LLC exchanged a warrant to purchase 192,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 192,600 shares of common stock. Mr. Schuyler has control over MVA 151 Investors LLC. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $6.25 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 3 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase common stock · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 2 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,600 Underlying: Common Stock · 89,600 shares Expires 2023-07-31 F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. Read SEC document |
| November 12, 2018 Filed Nov 25, 2020 21:51 UTC Amendment | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 89,600 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-20-039340 · ownership.xml · derivative · entry 1 Schuyler Kevin · CIK 0001718094 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Units · 179,200 shares Expires 2023-07-31 F1 · shares: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. F1 · price: The original warrant number and shares issuable upon exercise of the warrant is being corrected to reflect that on November 12, 2018, Mr. Schuyler exchanged a warrant to purchase 89,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 89,600 shares of common stock. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:11 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 162,200 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-010092 · ownership.xml · derivative · entry 12 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Owned by MVA 151 Investors, LLC Disclosed balance after: 162,200 Underlying: Units · 324,400 shares Expires 2023-07-31 F5 · price: The warrant to purchase 162,200 units was received by MVA 151 Investors LLC upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 324,400 shares. F5 · derivative.underlying: The warrant to purchase 162,200 units was received by MVA 151 Investors LLC upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 324,400 shares. F6 · ownership.nature: Mr. Schuyler has control over MVA 151 Investors, LLC. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 20:11 UTC | ADIAL PHARMACEUTICALS, INC. ADIL · Entity 7742 | OtherWarrant to purchase units · Derivative | 120,000 | Not disclosed Strike: $5.00 | Not disclosed |
DisclosureSEC source: 0001213900-18-010092 · ownership.xml · derivative · entry 11 Schuyler Kevin · CIK 0001718094 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Units · 240,000 shares Expires 2023-07-31 F4 · price: The warrant to purchase 120,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 240,000 shares. F4 · derivative.underlying: The warrant to purchase 120,000 units was received by the reporting person upon consummation of the initial public offering in accordance with a Securities Purchase Agreement dated February 22, 2018. Each unit consisted of a share of common stock and a warrant to purchase a share of common stock. The aggregate number of shares of common stock included in the units and underlying the warrants included in the units is 240,000 shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.